Scarica l'app Stockscreener
7.305
1.60%
0.145
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Rocket Pharmaceuticals Inc Borsa (RCKT) Ultime notizie
Rocket Pharmaceuticals Inc (RCKT)’s Market Momentum: Closing Strong at 7.16, Down -0.97 - DWinneX
Rocket Pharmaceuticals Inc (RCKT) stock analysis: A simple moving average approach - uspostnews.com
Rocket Pharmaceuticals Inc [RCKT] Insider Activity: An Update for Investors - knoxdaily.com
Is Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Stock Worth Investing In for High Returns? - Marketing Sentinel
Rocket Pharmaceuticals appoints new board member - MSN
RCKT stock touches 52-week low at $10.11 amid market challenges - MSN
RCKT stock touches 52-week low at $9.76 amid market challenges - MSN
Rocket Pharmaceuticals Inc (NASDAQ:RCKT) Could Actually Go To 39 In 12 Months - Marketing Sentinel
Understanding the Risks of Investing in Rocket Pharmaceuticals Inc (RCKT) - knoxdaily.com
Financial Metrics Exploration: Understanding Rocket Pharmaceuticals Inc (RCKT) Through Ratios - DWinneX
The Future of Rocket Pharmaceuticals Inc: Analyzing RCKT - investchronicle.com
Rocket Pharmaceuticals Inc [RCKT] Revenue clocked in at $0.00 million, down -42.96% YTD: What’s Next? - dbtnews.com
Our Attention Has Been Attracted to Rocket Pharmaceuticals Inc (NASDAQ:RCKT) - uspostnews.com
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Sold by Alliancebernstein L.P. - Defense World
Geode Capital Management LLC Increases Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
(RCKT) Trading Report - news.stocktradersdaily.com
JPMorgan Chase & Co. Sells 41,024 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
3 Stocks Insiders Are Buying Rapidly Amid Market Volatility - Investing.com
Is Rocket Pharmaceuticals (NASDAQ:RCKT) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Countdown To Approval: Rocket Pharma's Gene Therapy For Rare Disease Awaits FDA Decision - RTTNews
Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Up After Insider Buying Activity - Defense World
Rocket Pharmaceuticals CEO buys $101.6K in common stock - MSN
Rocket Pharmaceuticals CEO Gaurav Shah acquires $101,600 in stock By Investing.com - Investing.com India
Rocket Pharmaceuticals CEO Gaurav Shah acquires $101,600 in stock - Investing.com Australia
If You Don’t Buy Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Now, You’ll Kick Yourself Later - stocksregister.com
Raymond James Financial Inc. Makes New $285,000 Investment in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals (NASDAQ:RCKT) Earns Buy Rating from Needham & Company LLC - Defense World
Rocket Pharmaceuticals executive Kinnari Patel buys $99,165 in stock By Investing.com - Investing.com South Africa
Rocket Pharmaceuticals executive Kinnari Patel buys $99,165 in stock - Investing.com
Rocket Pharma Out Of Orbit, But Ready For Re-Launch (NASDAQ:RCKT) - Seeking Alpha
The Escalator: Rocket Pharmaceuticals, Zenas BioPharma, Angelini Ventures - Medical Marketing and Media
Corebridge Financial Inc. Sells 2,469 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Vanguard Group Inc. Purchases 1,040,655 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals (RCKT): Among Stocks Under $10 that Will Triple - Insider Monkey
KLP Kapitalforvaltning AS Buys Shares of 15,300 Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals CFO sells $39,646 in stock By Investing.com - Investing.com India
Rocket Pharmaceuticals CFO sells $39,646 in stock - Investing.com
Rocket Pharmaceuticals CFO Sells Shares to Cover Tax Obligations - TradingView
10 Stocks Under $10 that Will Triple - Insider Monkey
BMO maintains Rocket Pharmaceuticals Outperform rating By Investing.com - Investing.com UK
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Rocket Pharmaceuticals appoints new Chief Officer By Investing.com - Investing.com Canada
Rocket Pharmaceuticals appoints new Chief Officer - Investing.com Australia
Rocket Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference - BioSpace
Genetic Therapy Breakthroughs: Rocket Pharma CEO Set to Reveal Strategic Updates at Major Healthcare Conference - Stock Titan
Thrivent Financial for Lutherans Sells 21,731 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
RCKT stock plunges to 52-week low, hitting $5.68 - Investing.com
Is Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) the Best US Stock Under $10 to Buy Right Now? - MSN
Where are the Opportunities in (RCKT) - news.stocktradersdaily.com
Teacher Retirement System of Texas Raises Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 1-Year LowHere's Why - MarketBeat
Swiss National Bank Has $1.93 Million Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Swiss National Bank Buys 29,100 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - The AM Reporter
RCKT Stock Plummets to 52-Week Low, Hits $8.06 Amid Market Struggles - Investing.com UK
Rocket Pharmaceuticals’ SWOT analysis: gene therapy stock poised for growth amid challenges By Investing.com - Investing.com South Africa
Rocket Pharmaceuticals’ SWOT analysis: gene therapy stock poised for growth amid challenges - Investing.com India
1.36%
0.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):